AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel

Oct 22, 2007, 01:00 ET from AcroMetrix

    BENICIA, Calif., Oct. 22 /PRNewswire/ -- AcroMetrix, the leading
 provider of quality control standards for clinical diagnostic and blood
 testing laboratories, announced that they have enhanced their OptiQuant
 HIV-1 Quantification Panel to be the first to utilize an EDTA-based normal
 human plasma matrix. This product is for Research Use Only, not for use in
 diagnostic procedures.
     This new matrix, called OptiMatrix, allows the OptiQuant HIV-1 panel to
 most closely mimic a patient sample. The commutability of the OptiQuant HIV
 panel ensures accurate comparison and compatibility between a wide variety
 of testing platforms globally. As a further improvement, AcroMetrix panel
 members are the first to be directly traceable to International Units per
 milliliter (IU/mL) to facilitate global quality through ISO standards.
     "The OptiQuant HIV-1 Quantification Panel represents our commitment to
 standardization in diagnostics," said Michael J. Eck, President and CEO.
 "The new OptiQuant panel is the first HIV validation panel available to be
 traceable to the WHO standard, in a truly commutable matrix."
     This new OptiQuant HIV Panel fully complies with the ISO 17511:2003 (In
 vitro diagnostic medical devices -- Measurement of quantities in biological
 samples -- Metrological traceability of values assigned to calibrators and
 control materials) standard. Through the ISO 17511 standard, AcroMetrix
 aims to facilitate a uniform global quality control network by producing
 consistent and traceable universal standards.
     "Our goal is to standardize diagnostic testing so that a patient can
 receive a truly comparable test result regardless of the doctor or
 laboratory they choose to visit," said Mr. Eck, "The new OptiQuant HIV
 panel is a step in that direction for HIV viral load testing."
     About AcroMetrix
     AcroMetrix, with facilities in Benicia, California and Alkmaar, the
 Netherlands, provides a comprehensive line of molecular and serological
 diagnostic quality control products that assist laboratories in meeting
 current government regulations regarding quality. AcroMetrix maintains this
 leadership role by consistently developing innovative standards, external
 run controls, and validation kits for molecular and serological testing in
 blood screening and clinical diagnostic laboratories. For more information
 on AcroMetrix please visit the company web site at

SOURCE AcroMetrix